BioSpace News Archive

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), today announced that the Company plans to hold a clinical update call on June 13 after the European Hematology Association 2022 Hybrid Congress (EHA 2022) as the data is subject to meeting’s embargo policy until June 12.

From early detection to remote monitoring and data sharing, GE Healthcare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational efficiency, and outcomes for cancer patients.

The chromatography resins market size is expected to reach USD 4.81 Billion in 2030 and register a revenue CAGR of 8.0% over the forecast period, according to the latest report by Reports and Data.

The global DNA polymerase market size is expected to reach USD 568.3 Million in 2030 and register a revenue CAGR of 6.4% over the forecast period, according to latest report by Reports and Data.

According to the current analysis of Reports and Data, the global succinic acid market was valued at USD 1,027.78 Million in 2021 and is expected to reach USD 3,613.27 million by the year 2030, at a CAGR of 18.01%.

Increasing prevalence of various types of cancers worldwide, ongoing research on cancer, growing demand for precision medicine, and rapid adoption of advanced technologies in the healthcare sector are some key factors expected to drive global Oncology Informatics market growth.

ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases, is pleased to announce sponsorship of an American Diabetes Association Thought Leadership Video on Podocyte Lipotoxicity, a Cause of Diabetic Kidney Disease and Its Progression.

According to Nova one advisor, during the forecast period of 2022 to 2030, the global Digital Health market is estimated to develop at a compound annual growth rate (CAGR) of 27.9%.

According to Nova one advisor, during the forecast period of 2022 to 2030, the global Horseradish Peroxidase market is estimated to develop at a compound annual growth rate (CAGR) of 7.9%.

According to Nova one advisor, during the forecast period of 2022 to 2030, the global Solitary Fibrous Tumor Treatment market is estimated to develop at a compound annual growth rate (CAGR) of 4.5%.